{
  "trial_id": "NCT03066830",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, body mass index (BMI), baseline Hemoglobin A1c (HbA1c), baseline fasting plasma glucose (FPG), baseline systolic blood pressure (SBP), baseline diastolic blood pressure (DBP), duration of type 2 diabetes mellitus, use of Sulfonylurea, use of Metformin, history of severe hypoglycemia, liver function tests (aspartate aminotransferase, alanine aminotransferase, total bilirubin), use of systemic glucocorticoids, pregnancy status, breastfeeding status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Hemoglobin A1c (HbA1c)",
          "baseline Hemoglobin A1c (HbA1c)"
        ],
        [
          "Systolic Blood Pressure (SBP)",
          "baseline systolic blood pressure (SBP)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "baseline fasting plasma glucose (FPG)",
        "baseline diastolic blood pressure (DBP)",
        "duration of type 2 diabetes mellitus",
        "use of Sulfonylurea",
        "use of Metformin",
        "history of severe hypoglycemia",
        "liver function tests (aspartate aminotransferase, alanine aminotransferase, total bilirubin)",
        "use of systemic glucocorticoids",
        "pregnancy status",
        "breastfeeding status"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Fasting Plasma Glucose, Systolic Blood Pressure, Diastolic Blood Pressure, Body Weight, Duration of Diabetes, Use of Sulfonylurea, Use of Metformin,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Hemoglobin A1c (HbA1c)",
          "Baseline HbA1c"
        ],
        [
          "Systolic Blood Pressure (SBP)",
          "Systolic Blood Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Fasting Plasma Glucose",
        "Diastolic Blood Pressure",
        "Body Weight",
        "Duration of Diabetes",
        "Use of Sulfonylurea",
        "Use of Metformin"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Hemoglobin A1c, Fasting Plasma Glucose, Duration of Diabetes, Sulfonylurea Dose, Metformin Dose.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Hemoglobin A1c (HbA1c)",
          "Hemoglobin A1c"
        ],
        [
          "Systolic Blood Pressure (SBP)",
          "Systolic Blood Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Diastolic Blood Pressure",
        "Fasting Plasma Glucose",
        "Duration of Diabetes",
        "Sulfonylurea Dose",
        "Metformin Dose"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, hemoglobin A1c (HbA1c) at baseline, fasting plasma glucose (FPG) at baseline, systolic blood pressure (SBP) at baseline, diastolic blood pressure (DBP) at baseline, body weight at baseline, sulfonylurea dose at baseline, metformin dose at baseline.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Hemoglobin A1c (HbA1c)",
          "hemoglobin A1c (HbA1c) at baseline"
        ],
        [
          "Systolic Blood Pressure (SBP)",
          "systolic blood pressure (SBP) at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Male"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "fasting plasma glucose (FPG) at baseline",
        "diastolic blood pressure (DBP) at baseline",
        "body weight at baseline",
        "sulfonylurea dose at baseline",
        "metformin dose at baseline"
      ]
    }
  }
}